Tali Digital Ltd · ASX:TD1
Tali Digital — Shareholder Meeting (November 2020)
28 slides from Tali Digital's shareholder meeting presentation, Nov 24, 2020
Slide 1: 2020 Annual General Meeting
For personal use only TALi DIGITAL (ASX: TD1) 2020 Annual General Meeting November 2020 Happier kids start here. talihealth.com
Slide 2: Agenda
Agenda For personal use only Welcome and introductions Chairman’s Address CEO’s Address Formal business of the Meeting
Slide 3: Chairman's Address
For personal use only Chairman’s Address Sue MacLeman
Slide 4: CEO's Address
For personal use only CEO’s Address Glenn Smith
Slide 5: The market opportunity
For personal use only The market opportunity. Global problem, global market.
Slide 6: Evidence-based digital tool
Evidence-based digital tool For personal use only TALi has developed an evidence based digital health platform that makes a real difference in the lives of children with attention and learning difficulties. The technology combines 25+ years of research in developmental psychology and cognitive neuro
Slide 7: TALi delivered via smartphone or tablet devices
TALi — delivered via smartphone or tablet devices. For personal use only TALi DETECT Access via initial assessment through one-off payment. TALi TRAIN Access via 25 x 20min sessions through one-off payment or volume price point for B2B customers. TALi MAINTAIN Planned access via twelve month “booste
Slide 8: Attention profile and real-time status reports
Attention profile and real-time status reports For personal use only TALi Reports Evidence-based algorithms produce a detailed summary of attention-based and activities-based performance across three different domains of cognitive attention. The results are benchmarked against a standard deviation c
Slide 9: Dashboard to manage assessment and training data
Dashboard to manage assessment and training data For personal use only TALi Portal Assessment, compliance and progression data sets are accessible via the TALi Portal by administrators of the program. Accessibility and administration capabilities customisable for large institutions and networks.
Slide 10: TALi DETECT
TALi DETECT Evidence shows TALi DETECT can be the new clinical standard. For personal use only TALi DETECT Validity DETECT TEA-CH2J Strength of Result Initial results highlight Using Structural equation modelling (SEM), it was confirmed that game Game correlation program works in a DETECT subtests c
Slide 11: TALi TRAIN
TALi TRAIN Clinical evidence shows TALi TRAIN creates sustained benefits. For personal use only TALi TRAIN Rationale Computerised attention This study aimed to assess the immediate and long-term efficacy Selective Attention Accuracy training for children with of a computerised attention training pro
Slide 12: TALi TRAIN
TALi TRAIN Clinical evidence shows TALi TRAIN creates sustained benefits. For personal use only TALi TRAIN Rationale Impact of attention The aim of this study was to investigate the efficacy of Numeracy Skills training on academic computerised attention training (TALi TRAIN) on untrained achievement
Slide 13: TALi Advisory Board
TALi | Advisory Board For personal use only Dr Scott Kollins Professor Con Stough Dr Scott Kollins from the Duke University School of Medicine based Con Stough is a Professor of Cognitive Neuroscience and in the U.S. lends his expertise and thought leadership to support Psychology at Swinburne Unive
Slide 14: TALi Advisory Board
TALi | Advisory Board For personal use only Sarah Michel Dr Phil Lambert Sarah Michel, MPH, PMP brings her global experience in the Dr Phil Lambert has extensive experience in education as a commercialisation of evidence-based health innovations to the teacher, school principal, inspector, Executive
Slide 15: Commercial rollout
For personal use only Commercial rollout.
Slide 16: Commercial rollout: Start local. Go global.
Commercial rollout Start local. Go global. For personal use only Estimated children aged 3–8 1. Source: https://datacenter.kidscount.org/ 2. Source: https://www.statista.com/statistics/478558/children-population-percentage-of-total-united-kingdom-uk/ 3. Source: https://www.humanium.org/en/india/ 4.
Slide 17: B2B & B2C in Australia
Commercial rollout | Australia For personal use only B2B & B2C in Australia. Parents Healthcare providers Schools Parents can positively impact their child’s It is clinically proven and well-known Early intervention will present future development if signs of attention amongst the clinical community
Slide 18: Early release program
Commercial rollout | Early release program For personal use only Participation numbers at a glance: 30 schools
Slide 19: Commercial rollout | Australia
Commercial rollout | Australia For personal use only 4087 DETECT assessments completed. 1562 81% 75% TRAIN programs of children showing of children showing commenced or completed. inattention hyperactivity improvements. improvements.
Slide 20: Customer journey
Commercial rollout | Customer journey For personal use only
Slide 21: Partners and providers
Partners and providers For personal use only TALi is working with a range of partners and providers to distribute assessment and training programs to children around the country. Minderoo Foundation is Andrew Forrest’s private foundation. Sonic Learning is a national provider of online training prog
Slide 22: International partnership model
International partnership model For personal use only Google Education Partner Status is a significant opportunity for TALi. Access TALi via Google products Streamlined with US ed. system Backbone for revenue growth Allows TALi to be accessed via Google Google dominate US ed. system with This partne
Slide 23: International partnership & licensing model: US and India
Commercial rollout | International International partnership & licensing model. For personal use only United States India Seeking partners to roll out TALi under licensing and Soft launch of TALi DETECT & TRAIN in selected re-seller model through USA healthcare network. markets via activation of app
Slide 24: International partnership & licensing model: Japan and UK
Commercial rollout | International International partnership & licensing model. For personal use only Japan UK Seeking partners to roll out TALi under licensing and Identifying early adopters and KOL’s with a clinical channel model through Japanese healthcare and emphasis & continuing discussions wi
Slide 25: Revenue model
Revenue model For personal use only Number of children taking Cost per test TALi DETECT B2C Revenue Number of children taking Cost per training program TALi TRAIN B2B Revenue Licensing fee Royalty per child Licensing revenue
Slide 26: Outlook
For personal use only Outlook Delivering TALi to a million children in three years.
Slide 27: Outlook
Outlook For personal use only TALi in 2023 International distribution Government contracts TALi will be used by over one million children Rapid expansion of TALi’s global footprint will Long-term sustainability and guaranteed around the world by the end of 2023. be secured via international partners
Slide 28: Happier kids start here
For personal use only Happier kids start here. For further information, please contact the TALi team: e. info@talihealth.com | p. 1300 082 013 | w. talihealth.com